Health insurance to cover Afinitor

Published: 2011-07-19 06:57:00

Updated: 2011-07-19 06:57:00

The negotiation ended Friday after a compromise was reached between the National Health Insurance Corp. and Novartis Korea on the insurance price of Afinitor (everolimus), a cancer drug to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a ra...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK